Lymphoseek FDA Approval History
Last updated by Judith Stewart, BPharm on Aug 6, 2021.
FDA Approved: Yes (First approved March 13, 2013)
Brand name: Lymphoseek
Generic name: technetium Tc 99m tilmanocept
Dosage form: Injection
Company: Navidea Biopharmaceuticals
Treatment for: Diagnosis and Investigation
- Lymphatic mapping using a handheld gamma counter to locate lymph nodes draining a primary tumor site in adult and pediatric patients age one month and older with solid tumors for which this procedure is a component of intraoperative management.
- Guiding sentinel lymph node biopsy using a handheld gamma counter in patients with clinically node negative squamous cell carcinoma of the oral cavity, breast cancer or melanoma.
Development timeline for Lymphoseek
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.